PET/CT, MR, and PET/MR in Lymphoma and Melanoma

被引：25

作者：

Schwenzer, Nina F. ^{[1
]}

Pfannenberg, Anna Christina ^{[1
]}

机构：

[1] Univ Tubingen, Dept Radiol Diagnost & Intervent Radiol, D-72076 Tubingen, Germany

来源：

SEMINARS IN NUCLEAR MEDICINE | 2015年 / 45卷 / 04期

关键词：

POSITRON-EMISSION-TOMOGRAPHY; B-CELL LYMPHOMA; WHOLE-BODY MRI; DIFFUSION-WEIGHTED MRI; CLINICAL-PRACTICE GUIDELINES; BONE-MARROW INFILTRATION; NON-HODGKINS-LYMPHOMA; PRIMARY CNS LYMPHOMA; FDG-PET; METASTATIC MELANOMA;

D O I：

10.1053/j.semnuclmed.2015.03.006

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

With the introduction of hybrid imaging technologies such as PET/CT and recently PET/MRI, staging and therapy-response monitoring have evolved. PET/CT has been shown to be of value for routine staging of FDG-avid lymphomas before as well as at the end of treatment. For interim staging, trials are ongoing to evaluate the use of PET/CT. In melanoma, PET/CT can be recommended for stages III and IV diseases for initial staging and before surgery. Studies investigating the use of PET/CT for early therapy response are promising. The role of PET/MR in lymphoma and melanoma imaging has to be defined because no larger studies exist so far. There may be an application of PET/MR in research especially for tumor characterization and therapy response. Furthermore, the potential role of non-FDG tracers is elucidated regarding the assessment of treatment response in targeted drug regimens. (C) 2015 Elsevier Inc. All rights reserved.

引用

页码：322 / 331

页数：10

共 139 条

[1] Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients [J].

Abdulqadhr, Goran ;

Molin, Daniel ;

Astrom, Gunnar ;

Suurkula, Madis ;

Johansson, Lars ;

Hagberg, Hans ;

Ahlstrom, Hakan .

ACTA RADIOLOGICA, 2011, 52 (02) :173-180

[2] Differential Expression of Micro RNAs Accompanies Differential Reactivity Via Platelet FcγRIIa in Humans and Transgenic Mice [J].

Abraham, Shaji ;

Andre, Pierrette ;

Zhou, Yuhang ;

Edelstein, Leonard C. ;

Shaw, Chad ;

Bray, Paul F. ;

McKenzie, Steven E. .

BLOOD, 2012, 120 (21)

[3] Sarcoidosis associated with vemurafenib [J].

Adam, A. ;

Thomas, L. ;

Bories, N. ;

Zaharia, D. ;

Balme, B. ;

Freymond, N. ;

Dalle, S. .

BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (01) :206-208

[4] Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma [J].

Adams, Hugo J. A. ;

Kwee, Thomas C. ;

Fijnheer, Rob ;

Dubois, Stefan V. ;

Nievelstein, Rutger A. J. ;

de Klerk, John M. H. .

AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (07) :726-731

[5] Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4 [J].

Attia, P ;

Phan, GQ ;

Maker, AV ;

Robinson, MR ;

Quezado, MM ;

Yang, JC ;

Sherry, RM ;

Topalian, SL ;

Kammula, US ;

Royal, RE ;

Restifo, NP ;

Haworth, LR ;

Levy, C ;

Mavroukakis, SA ;

Nichol, G ;

Yellin, MJ ;

Rosenberg, SA .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :6043-6053

[6] Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era [J].

Avivi, Irit ;

Zilberlicht, Ariel ;

Dann, Eldad J. ;

Leiba, Ronit ;

Faibish, Tal ;

Rowe, Jacob M. ;

Bar-Shalom, Rachel .

AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (05) :400-405

[7] End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphoma [J].

Barnes, J. A. ;

LaCasce, A. S. ;

Zukotynski, K. ;

Israel, D. ;

Feng, Y. ;

Neuberg, D. ;

Toomey, C. E. ;

Hochberg, E. P. ;

Canellos, G. P. ;

Abramson, J. S. .

ANNALS OF ONCOLOGY, 2011, 22 (04) :910-915

[8] Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group [J].

Barrington, Sally F. ;

Mikhaeel, N. George ;

Kostakoglu, Lale ;

Meignan, Michel ;

Hutchings, Martin ;

Mueeller, Stefan P. ;

Schwartz, Lawrence H. ;

Zucca, Emanuele ;

Fisher, Richard I. ;

Trotman, Judith ;

Hoekstra, Otto S. ;

Hicks, Rodney J. ;

O'Doherty, Michael J. ;

Hustinx, Roland ;

Biggi, Alberto ;

Cheson, Bruce D. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :3048-+

[9] Prognostic value of the standardized uptake value for 18F-fluorodeoxyglucose in patients with stage IIIB melanoma [J].

Bastiaannet, E. ;

Hoekstra, O. S. ;

de Jong, J. R. ;

Brouwers, A. H. ;

Suurmeijer, A. J. H. ;

Hoekstra, H. J. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (10) :1592-1598

[10] Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI [J].

Beloueche-Babari, M. ;

Jamin, Y. ;

Arunan, V. ;

Walker-Samuel, S. ;

Revill, M. ;

Smith, P. D. ;

Halliday, J. ;

Waterton, J. C. ;

Barjat, H. ;

Workman, P. ;

Leach, M. O. ;

Robinson, S. P. .

BRITISH JOURNAL OF CANCER, 2013, 109 (06) :1562-1569

← 1 2 3 4 5 6 7 8 9 10 →